Shopping Cart
- Remove All
- Your shopping cart is currently empty
oxepinac is an effective and well-tolerated compound for the treatment of painful osteoarthritis. oxepinac has no teratogenic effect on mouse and rabbit fetuses in animal experiments.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | 135 € | In Stock | |
5 mg | 335 € | In Stock | |
10 mg | 480 € | In Stock | |
25 mg | 729 € | In Stock | |
50 mg | 978 € | In Stock | |
100 mg | 1.320 € | In Stock | |
200 mg | 1.786 € | In Stock |
Description | oxepinac is an effective and well-tolerated compound for the treatment of painful osteoarthritis. oxepinac has no teratogenic effect on mouse and rabbit fetuses in animal experiments. |
Targets&IC50 | Aldose reductase (rabbit lens):0.33 μM |
In vivo | Teratogenic effects of 6,11-dihydro-11-oxodibenz[b,e]oxepin-3-acetic acid (oxepinac) were examined in mice and rabbits. Oxepinac was orally given to pregnant animals during the organogenesis period at 3, 30 and 90 mg/kg/day for mice, and at 3, 10 and 20 mg/kg/day for rabbits. It can be concluded that oxepinac has no teratogenic effect on fetuses in mice and rabbits. In addition, the medication of oxepinac to pregnant mice does not adversely affect the postnatal development of their pups.[1] |
Molecular Weight | 268.26 |
Formula | C16H12O4 |
Cas No. | 55689-65-1 |
Smiles | O=C1C=2C(=CC(CC(O)=O)=CC2)OCC=3C1=CC=CC3 |
Storage | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 55 mg/mL (205.02 mM) | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.